Upgrade to SI Premium - Free Trial

Navidea Biopharmaceuticals (NAVB) Files $100M Mixed Shelf; 3.17M Common for Shareholders

May 9, 2014 8:23 AM
Navidea Biopharmaceuticals (AMEX: NAVB) filed a registration with the U.S. SEC to sell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Equity Offerings

Next Articles